Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Options Exercise Instructions
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

Independent Research Validates Biotron HCV Drug Candidate

27 November 2013 by Justine Bednorz

Independent Research Validates Biotron HCV Drug Candidate

Categories 2013, ASX Announcements
Post navigation
Ethics Approval for New HCV Three Month Dosing Study
Presentation of HIV Data at International HIV Persistence Meeting
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 2 May 2022        Legal Notices and Privacy